Pharmacogenomic Cluster Analysis of Lung Cancer Cell Lines Provides Insights into Preclinical Model Selection in NSCLC

Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

Graham S, Shaban M, Qaiser T et al (2018) Classification of lung cancer histology images using patch-level summary statistics. In: Med Imaging 2018: Digit Pathol. https://doi.org/10.1117/12.2293855

Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics, 2000. CA Cancer J Clin 50:7–33. https://doi.org/10.3322/canjclin.50.1.7

Hutter C, Zenklusen JC (2018) The cancer genome atlas: creating lasting value beyond its data. Cell 173:283–285. https://doi.org/10.1016/j.cell.2018.03.042

Zhang J, Bajari R, Andric D et al (2019) The international cancer genome consortium data portal. Nat Biotechnol 37:367–369. https://doi.org/10.1038/s41587-019-0055-9

Hammerman PS, Lawrence MS, Voet D et al (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature 489:519–525. https://doi.org/10.1038/nature11404

Collisson EA, Campbell JD, Brooks AN et al (2014) Comprehensive molecular profiling of lung adenocarcinoma. Nature 511:543–550. https://doi.org/10.1038/nature13385

Herbst RS, Morgensztern D, Boshoff C (2018) The biology and management of non-small cell lung cancer. Nature 553:446–454. https://doi.org/10.1038/nature25183

Kim HS, Mitsudomi T, Soo RA, Cho BC (2013) Personalized therapy on the horizon for squamous cell carcinoma of the lung. Lung Cancer 80:249–255. https://doi.org/10.1016/j.lungcan.2013.02.015

Yuan M, Huang L-L, Chen J-H et al (2019) The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther 4:61–61. https://doi.org/10.1038/s41392-019-0099-9

Goodspeed A, Heiser LM, Gray JW, Costello JC (2016) Tumor-derived cell lines as molecular models of cancer pharmacogenomics. Mol Cancer Res 14:3–13. https://doi.org/10.1158/1541-7786.MCR-15-0189

Barretina J, Caponigro G, Stransky N et al (2012) The Cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483:603–607. https://doi.org/10.1038/nature11003

Yang W, Soares J, Greninger P et al (2013) Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 41:D955–D961. https://doi.org/10.1093/nar/gks1111

Tate JG, Bamford S, Jubb HC et al (2019) COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res 47:D941–D947. https://doi.org/10.1093/nar/gky1015

Mouradov D, Sloggett C, Jorissen RN et al (2014) Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. Cancer Res 74:3238–3247. https://doi.org/10.1158/0008-5472.CAN-14-0013

Sinha R, Winer AG, Chevinsky M et al (2017) Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection. Nat Commun 8:15165. https://doi.org/10.1038/ncomms15165

Landa I, Pozdeyev N, Korch C et al (2019) Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies. Clin Cancer Res 25:3141–3151. https://doi.org/10.1158/1078-0432.CCR-18-2953

Najgebauer H, Yang M, Francies HE et al (2020) CELLector: genomics-guided selection of cancer in vitro models. Cell Syst 10:424-432.e6. https://doi.org/10.1016/j.cels.2020.04.007

Zhao N, Liu Y, Wei Y et al (2017) Optimization of cell lines as tumour models by integrating multi-omics data. Brief Bioinform 18:515–529. https://doi.org/10.1093/bib/bbw082

Hynds RE, Frese KK, Pearce DR et al (2021) Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories. Open Biol 11:200247. https://doi.org/10.1098/rsob.200247

Stransky N, Ghandi M, Kryukov GV et al (2015) Pharmacogenomic agreement between two cancer cell line data sets. Nature 528:84–87. https://doi.org/10.1038/nature15736

Goldman M, Craft B, Brooks A et al (2019) The UCSC Xena platform for public and private cancer genomics data visualization and interpretation. bioRxiv. https://doi.org/10.1101/326470

Ding Z, Zu S, Gu J (2016) Evaluating the molecule-based prediction of clinical drug responses in cancer. Bioinformatics 32:2891–2895. https://doi.org/10.1093/bioinformatics/btw344

Skidmore ZL, Wagner AH, Lesurf R et al (2016) GenVisR: genomic visualizations in R. Bioinformatics 32:3012–3014. https://doi.org/10.1093/bioinformatics/btw325

Akbani R, Akdemir KC, Aksoy BA et al (2015) Genomic classification of cutaneous melanoma. Cell 161:1681–1696. https://doi.org/10.1016/j.cell.2015.05.044

Nazari Z, Kang D, Asharif MR et al (2015) A new hierarchical clustering algorithm. In: 2015 Int Conf Intell Inform Biomed Sci (ICIIBMS). https://doi.org/10.1109/ICIIBMS.2015.7439517

P S, Gupta S, (2011) A comparative study on distance measuring approaches for clustering. Int J Res Comput Sci 2:29–31. https://doi.org/10.7815/ijorcs.21.2011.011

Ward JH (1963) Hierarchical grouping to optimize an objective function. J Am Stat Assoc 58:236–244. https://doi.org/10.1080/01621459.1963.10500845

Xu Q, Zhang Q, Liu J, Luo B (2020) Efficient synthetical clustering validity indexes for hierarchical clustering. Expert Syst Appl 151:113367. https://doi.org/10.1016/j.eswa.2020.113367

Nana FA, Lecocq M, Ladjemi MZ et al (2019) Therapeutic potential of focal adhesion kinase inhibition in small cell lung cancer. Mol Cancer Ther 18:17–27. https://doi.org/10.1158/1535-7163.MCT-18-0328

Hecker L (2018) Mechanisms and consequences of oxidative stress in lung disease: therapeutic implications for an aging populace. Am J Physiol-Lung Cell Mol Physiol 314:1642–1653. https://doi.org/10.1152/ajplung.00275.2017

Inamura K (2017) Lung cancer: understanding its molecular pathology and the 2015 WHO classification. Front Oncol 7:193. https://doi.org/10.3389/fonc.2017.00193